Compare NWL & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NWL | OMCL |
|---|---|---|
| Founded | 1903 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Computer Manufacturing |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | N/A | 2001 |
| Metric | NWL | OMCL |
|---|---|---|
| Price | $3.83 | $44.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $5.88 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 8.8M | 511.1K |
| Earning Date | 10-31-2025 | 10-30-2025 |
| Dividend Yield | ★ 7.35% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $7,256,000,000.00 | $1,177,740,000.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | $0.60 | $3.97 |
| P/E Ratio | ★ N/A | $103.10 |
| Revenue Growth | N/A | ★ 10.67 |
| 52 Week Low | $3.07 | $22.66 |
| 52 Week High | $11.54 | $47.69 |
| Indicator | NWL | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 53.21 | 73.35 |
| Support Level | $3.67 | $39.18 |
| Resistance Level | $3.93 | $45.36 |
| Average True Range (ATR) | 0.17 | 1.91 |
| MACD | 0.06 | 0.36 |
| Stochastic Oscillator | 78.85 | 88.77 |
Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.